Search

Purpose The intention of this systematic review was to analyze the literature on breast cancer (BC) and the use of the levonorgestrel-releasing intrauterine system (LNG-IUS). Methods The literature was searched in Medline, Embase, Cochrane Library, CINAHL, Web of Science and ClinicalTrials.com and included search terms related to breast cancer and LNG-IUS. After elimination of duplicates, 326 studies could be identified and were assessed according to inclusion and exclusion criteria. In the end, 10 studies met the defined criteria and were included in the systematic review. Results 6 out of the 10 selected studies were cohort studies, three were case–control studies and one a systematic review/meta-analysis. 6 found a positive association between BC and the use of LNG-IUS. One study only found an increased risk for invasive BC in the subgroup of women aged 40–45 years. In contrast, three studies showed no indication of a higher BC risk. Conclusion The results imply an increased BC risk in LNG-IUS users, especially in postmenopausal women and with longer duration of use. Positive effects of the LNG-IUS such as reduced risks for other hormonal cancers have been observed, were, however, not focus of this systematic review. The heterogeneity of the analyzed studies and vast number of confounding factors call for further investigations in this issue. Patients should be advised according to their individual risk profile and hormone-free alternatives may be considered for women with a history of BC.

7-Keto-DHEA has been commercially advertised as a dietary supplement to support weight loss. The objective of the present systematic review it to summarize the evidence supporting the use of 7-keto-DHEA in overweight and obese population. The systematic search was conducted in Medline, Embase, Cochrane Library, CINAHL, Web of Science, Scopus, ICTRP, and ClinicalTrials.gov. Additionally, reference lists of eligible studies were considered, and authors of relevant studies were contacted. Two authors independently screened the studies against the inclusion criteria and assessed their risk of bias. In total, 4 out of 686 studies were included in the review. They all held a low risk of bias. Half of them showed a significant reduction in body weight. One study found a decrease in body fat percentage and another one reported a decrease in BMI. Two studies stated an increase in resting metabolic rate. No serious adverse effects were reported. Various possible mechanisms in favor of weight loss are discussed; however, with the evidence currently available, no clear answer can be given regarding 7-keto-DHEA and weight loss. Further studies need to be conducted to clarify the efficacy and safety of this drug before it can be recommended for therapeutic use.

This search string covers the retrieval of information related to multiple trauma or polytrauma. The second part of the search string is optional, as it addresses specific traumata, which are sometimes also used in the polytrauma literature. The search string can be amended with the following more specific traumata, which are sometimes also used in the polytrauma literature: blunt trauma*[tiab] OR traumatic brain injur*[tw] OR craniocerebral trauma*[tw] OR cranio-cerebral trauma*[tw] OR cranial trauma* [tiab] OR chest trauma*[tw] OR chest wall trauma*[tw] OR thorax trauma*[tw] OR thoracic trauma*[tw] OR abdominal trauma*[tw] OR thoracoabdominal trauma*[tw] OR thoraco-abdominal trauma*[tw] OR pelvic trauma*[tw] OR pelvis trauma*"[tw] OR spinal trauma*[tw] OR spine trauma*[tw].

OBJECTIVE The aim of the present comprehensive review was to present an overview of the clinical presentation and treatment options for external (EJVAs) and internal jugular vein aneurysms (IJVAs) to help clinicians in evidence-based decision making. METHODS A systematic literature search was conducted in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) statement and included MEDLINE, Embase, Cochrane Library, Scopus, WHO (World Health Organization) trial register, ClinicalTrials.gov, and the LIVIVO search portal. The inclusion criteria were studies of patients who had presented with IJVAs or EJVAs. The exclusion criteria were animal and cadaver studies and reports on interventions using the healthy jugular vein for access only (ie, catheterization). Analysis of the pooled data from all eligible case reports was performed. RESULTS From 1840 identified reports, 196 studies were eligible. A total of 256 patients with JVAs were reported, with 183 IJVAs and 73 EJVAs. IJVAs were reported to occur in 66% on the right side compared with the left side (P��= .011). The patients with IJVAs were mostly children (median age, 12��years; interquartile range, 5.8-45.2��years). The patients with EJVAs were young adults (median age, 30��years; interquartile range, 11.0-46.5��years). EJVAs were more frequently reported in women and IJVAs in men (P��= .008). Most of the patients were asymptomatic. Pulmonary embolization in association with thrombosed EJVAs was only reported for one patient. A report of the outcomes after surgery and conservative management was missing for ���50% of the patients. No relevant complications were reported after ligation of the EJVA without reconstruction. Intracranial hypertension after ligation of the right-sided IJVA was reported in three children; in one of them, a pontine infarction was observed. CONCLUSIONS JVAs are a disease of the younger population but can occur at any age. It seems to be safe to observe patients with nonthrombosed JVAs. However, in the presence of thrombus or pulmonary embolization, surgical treatment should be considered. A reconstruction technique of the IJVA with venous patency preservation should be preferred.

The authors wish to make the following corrections to this paper [...]

Background: Microbeam Radiation Therapy (MRT) is an innovative approach in radiation oncology where a collimator subdivides the homogeneous radiation field into an array of co-planar, high-dose beams which are tens of micrometres wide and separated by a few hundred micrometres. Objective: This scoping review was conducted to map the available evidence and provide a comprehensive overview of the similarities, differences, and outcomes of all experiments that have employed animal models in MRT. Methods: We considered articles that employed animal models for the purpose of studying the effects of MRT. We searched in seven databases for published and unpublished literature. Two independent reviewers screened citations for inclusion. Data extraction was done by three reviewers. Results: After screening 5688 citations and 159 full-text papers, 95 articles were included, of which 72 were experimental articles. Here we present the animal models and pre-clinical radiation parameters employed in the existing MRT literature according to their use in cancer treatment, non-neoplastic diseases, or normal tissue studies. Conclusions: The study of MRT is concentrated in brain-related diseases performed mostly in rat models. An appropriate comparison between MRT and conventional radiotherapy (instead of synchrotron broad beam) is needed. Recommendations are provided for future studies involving MRT.

Androecium development and vasculature were studied in nine species of the Adansonieae clade (core Bombacoideae, Malvaceae s.l.). In early androecium development either distinct pentagonal androecial ring walls or five common petal/androecium primordia are present. Ring walls give rise to five antepetalous and five alternipetalous primary androecial primordia. Common primordia divide into peripheral petal primordia and antepetalous primary androecial primordia. Antepetalous primary androecial primordia split anticlinally into ten primordia-halves, on which secondary androecial primordia are initiated in a centrifugal succession. Androecial lobes are formed by fusion of an alternipetalous primary androecial primordium and its two neighbouring antepetalous primary primordia-halves, a pattern that also occurs in other Malvatheca. Later, tertiary androecial primordia are formed by the subdivision of secondary androecial primordia (except in Adansonia and Ceiba). Each tertiary primordium differentiates into a two-locular androecial unit. At anthesis these two-locular androecial units are often present in pairs, corresponding to the two halves of the same secondary androecial primordium. Androecium development and vasculature imply that the alternipetalous androecial sectors have been reduced in Bombacoideae, a tendency that is shared with other subfamilies of Malvaceae.

Androecial development and structure as well as floral vasculature of six selected species of Bombacoideae and of several smaller lineages of the Malvatheca clade (Malvaceae s.l.) were studied. All studied taxa share a similar pattern of androecial development: initially, five antepetalous/antetepalous and five alternipetalous/alternitepalous primary androecial primordia develop on a ring wall. Two elongate secondary androecial primordia form on each antepetalous/antetepalous sector. At anthesis the androecium consists of an androecial tube crowned by five androecial lobes. Each of these lobes is the developmental product of an alternipetalous/alternitepalous primary androecial primordium and its two neighbouring antepetalous/antetepalous secondary androecial primordia. The elongate, sessile androecial units are positioned along the lateral margins of the androecial lobes and in the distal part of the androecial tube. Seen in the light of the most recent studies of floral development and phylogeny of the Malvaceae and the Malvales as a whole, our data indicate that i) elongate, sessile androecial units are ancestral in the Malvatheca clade, that ii) an obdiplostemonous floral ground plan is a synapomorphy for the Malvaceae, and that iii) diplostemony is most likely ancestral in the Malvales.